Bayon Therapeutics

Brief Description

Bayon Therapeutics is an ophthalmic specialty pharmaceutical company using small molecules to restore the eyes’ ability to perceive and interpret vision in visually-impaired patients. Bayon was founded in 2020 with the focus on developing a novel platform of small molecules for visually-impaired patients with high unmet needs. The company's initial clinical trials focus on patients in later stages of disease progression due to retinitis pigmentosa, includinfg all sub-forms. After demonstrating safety and efficacy, Bayon plans to further develop the platform for use in patients with geographic atrophy, the later stages of age-related macular degeneration (dry AMD).

Formerly known as Yellowbrick Bio.


Rich Kramer

Tech Category

  • Medical Therapeutics

Join the IPIRA Mailing List




Accessibility | Nondiscrimination | Privacy